Canada markets close in 3 hours 46 minutes

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
44.84+0.86 (+1.96%)
As of 12:13PM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.41B
Enterprise Value 5.53B
Trailing P/E 114.71
Forward P/E 90.91
PEG Ratio (5 yr expected) 25.70
Price/Sales (ttm)7.99
Price/Book (mrq)16.57
Enterprise Value/Revenue 7.02
Enterprise Value/EBITDA -23.44

Trading Information

Stock Price History

Beta (5Y Monthly) 0.46
52-Week Change 323.23%
S&P500 52-Week Change 328.14%
52 Week High 354.44
52 Week Low 332.69
50-Day Moving Average 350.12
200-Day Moving Average 344.68

Share Statistics

Avg Vol (3 month) 31.21M
Avg Vol (10 day) 31.47M
Shares Outstanding 5145.75M
Implied Shares Outstanding 6143.47M
Float 8144.52M
% Held by Insiders 10.85%
% Held by Institutions 1102.74%
Shares Short (Jan 31, 2024) 48.45M
Short Ratio (Jan 31, 2024) 46.63
Short % of Float (Jan 31, 2024) 46.97%
Short % of Shares Outstanding (Jan 31, 2024) 45.89%
Shares Short (prior month Dec 29, 2023) 48.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023


Profit Margin -46.50%
Operating Margin (ttm)4.79%

Management Effectiveness

Return on Assets (ttm)-7.51%
Return on Equity (ttm)-76.34%

Income Statement

Revenue (ttm)787.65M
Revenue Per Share (ttm)5.50
Quarterly Revenue Growth (yoy)113.60%
Gross Profit (ttm)N/A
EBITDA -319.22M
Net Income Avi to Common (ttm)-366.29M
Diluted EPS (ttm)-2.56
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.34B
Total Cash Per Share (mrq)16.04
Total Debt (mrq)1.45B
Total Debt/Equity (mrq)375.71%
Current Ratio (mrq)5.90
Book Value Per Share (mrq)2.68

Cash Flow Statement

Operating Cash Flow (ttm)-307.51M
Levered Free Cash Flow (ttm)-166.79M